Individuals with cystic fibrosis (CF) frequently also suffer from diabetes, which worsens CF prognosis. CF is caused by mutation of the CFTR chloride channel, leading to dysfunction of several internal organs, including the pancreas. Recently, engineered ferret and pig models of CF have been developed that more closely recapitulate the disease than rodent models used previously. Olivier et al. now report on the early stages of pancreatic pathology and diabetes development in CF ferrets, which are more similar to humans than are pigs with respect to the progression of pancreatic disease after birth. The authors found early signs of abnormal insulin secretion and glucose tolerance in neonatal CF ferrets, before overt histopathological changes occurred in the pancreas. Pancreas pathology that was associated with inflammation and fibrosis progressed in the first month of life, with an age-dependent rise in blood glucose. Compared with non-CF ferrets, newborn CF ferrets had fewer large islets and, in vitro, islets from newborn CF ferrets showed abnormal glucose-responsive insulin secretion, despite high insulin content. These results suggest an intrinsic defect in islets of CF ferrets that is present at birth. Further studies could help to develop strategies for treatment or prevention of CF-related diabetes in humans.
CF-related diabetes: new insights from ferrets
CF-related diabetes: new insights from ferrets. Dis Model Mech 1 November 2012; 5 (6): 708. doi:
Download citation file:
Advertisement
Cited by
New Special Issue: Translating Multiscale Research in Rare Disease. Edited by Monica Justice, Monkol Lek, Karen Liu and Kate Rauen.
This special issue features original Research, Resources & Methods and Review-type articles that aim to interrogate the mechanisms of rare diseases to foster meaningful clinical progress in their diagnosis and treatment.
The role of the International Society for Stem Cell Research (ISSCR) guidelines in disease modelling
The ISSCR provides comprehensive guidelines and standards for using human stem cells in biomedical research. In this Editorial, Cody Juguilon and Joseph Wu discuss how and why these should be incorporated in disease modelling research.
Subject collection: Building advocacy into research
DMM’s series - Building advocacy into research - features interviews, ‘The Patient’s Voice’, with patients and advocates for a range of disease types, with the aim of supporting the highest quality research for the benefit of all patients affected by disease.
Read & Publish Open Access publishing: what authors say
We have had great feedback from authors who have benefitted from our Read & Publish agreement with their institution and have been able to publish Open Access with us without paying an APC. Read what they had to say.
Biologists @ 100 - join us in Liverpool in March 2025
We are excited to invite you to a unique scientific conference, celebrating the 100-year anniversary of The Company of Biologists, and bringing together our different communities. The conference will incorporate the Spring Meetings of the BSCB and the BSDB, the JEB Symposium Sensory Perception in a Changing World and a DMM programme on antimicrobial resistance. Find out more and register your interest to join us in March 2025 in Liverpool, UK.
Other journals from
The Company of Biologists